BrainStorm Cell Therapeutics
BCLI
#10372
Rank
ยฃ5.04 M
Marketcap
ยฃ0.46
Share price
-7.46%
Change (1 day)
-64.02%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -ยฃ8.27 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ8.57 Million, an increase over its 2023 earnings that were of -ยฃ12.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ8.27 Million-3.52%
2024 -ยฃ8.57 Million-32.39%
2023 -ยฃ12.68 Million-29.18%
2022 -ยฃ17.9 Million-0.74%
2021 -ยฃ18.03 Million-23.12%
2020 -ยฃ23.46 Million36.8%
2019 -ยฃ17.15 Million66.71%
2018 -ยฃ10.29 Million181.66%
2017 -ยฃ3.66 Million-0.6%
2016 -ยฃ3.68 Million-41.31%
2015 -ยฃ6.26 Million-8.22%
2014 -ยฃ6.82 Million89.74%
2013 -ยฃ3.6 Million42.27%
2012 -ยฃ2.53 Million-12.45%
2011 -ยฃ2.89 Million63.04%
2010 -ยฃ1.77 Million35.52%
2009 -ยฃ1.31 Million-48.99%
2008 -ยฃ2.56 Million-44.39%
2007 -ยฃ4.61 Million
2005 -ยฃ2.39 Million-91.44%
2004 -ยฃ27.86 Million94007.62%
2003 -ยฃ0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
ยฃ1.40 B-17,654.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.28 B-91,248.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-ยฃ0.59 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ0.56 Billion 6,832.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ15.23 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-ยฃ0.19 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA